share_log

Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.

Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.

bio-rad实验室股票上涨,花旗集团维持对该股的买入评级,并将其目标价从400美元上调至450美元。
Benzinga ·  2024/11/01 19:21

Bio-Rad Laboratories Shares Are Trading Higher After Citigroup Maintained a Buy Rating on the Stock and Raised Its Price Target From $400 to $450.

bio-rad实验室股票交易价格上涨,因为花旗集团维持对该股的买入评级,并将其目标价格从400美元上调至450美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发